Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Metromile Inc (MILE)

Metromile Inc (MILE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Lemonade Insurance Stock Rallied More Than 14% Last Week

It was a good week for all beaten-down growth stocks, insuretechs included.

LMND : 17.93 (+3.16%)
MILE : 1.0500 (+7.67%)
Why Lemonade's Stock Price Fell Nearly 3% Today

The insurance technology company has bounced around quite a bit the past few days

LMND : 17.93 (+3.16%)
AEG : 6.47 (+2.21%)
MILE : 1.0500 (+7.67%)
Everything You Need to Know About Lemonade's Upcoming Acquisition

Lemonade is set to close its acquisition of Metromile any day now, and here's what you need to know.

LMND : 17.93 (+3.16%)
MILE : 1.0500 (+7.67%)
1 Growth Stock Down 87% That Could Soar, Says Wall Street

This fintech company is growing its business nicely, despite what the stock price drop might imply.

LMND : 17.93 (+3.16%)
MILE : 1.0500 (+7.67%)
Is Lemonade Stock a Buy?

The online insurance company still faces a lot of long-term challenges.

LMND : 17.93 (+3.16%)
MILE : 1.0500 (+7.67%)
Down 90% From the Highs, Is Lemonade a Buy After Earnings?

Here's a rundown of the reasons for and against buying the insurance disruptor.

LMND : 17.93 (+3.16%)
MILE : 1.0500 (+7.67%)
Metromile, Inc. (MILE) Reports Q1 Loss, Tops Revenue Estimates

Metromile, Inc. (MILE) delivered earnings and revenue surprises of -170% and 78.44%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

MILE : 1.0500 (+7.67%)
IFS : 22.00 (+1.62%)
Oscar Health, Inc. (OSCR) Reports Q1 Loss, Tops Revenue Estimates

Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of 10% and 21.14%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OSCR : 18.97 (+5.27%)
MILE : 1.0500 (+7.67%)
Metromile Announces First Quarter 2022 Financial Results

SAN FRANCISCO, May 10, 2022 (GLOBE NEWSWIRE) -- Metromile, Inc. (“Metromile”) (NASDAQ: MILE, MILEW), a leading digital insurance platform and...

MILE : 1.0500 (+7.67%)
MILEW : 0.0586 (-54.75%)
Here's Why Lemonade Stock Jumped, Then Fell After Earnings

Investors are trying to digest the insurance tech company's latest results.

LMND : 17.93 (+3.16%)
MILE : 1.0500 (+7.67%)

Barchart Exclusives

After Its Historic Dividend Cut, Is 3M Stock Still Worth Buying?
3M stock is a Dividend King no more, as the company slashed its payout following the Solventum spinoff. Is the stock still a buy for investors seeking passive income? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar